• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑膜炎奈瑟菌外膜囊泡的连续生产。

Continuous production of Neisseria meningitidis outer membrane vesicles.

机构信息

Institute for Translational Vaccinology (Intravacc), Process Development Bacterial Vaccines, P.O. Box 450, 3720, AL, Bilthoven, The Netherlands.

Bioprocess Engineering, Wageningen University, P.O. Box 16, 6700, AA, Wageningen, The Netherlands.

出版信息

Appl Microbiol Biotechnol. 2019 Dec;103(23-24):9401-9410. doi: 10.1007/s00253-019-10163-z. Epub 2019 Nov 1.

DOI:10.1007/s00253-019-10163-z
PMID:31676919
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6867985/
Abstract

Outer membrane vesicles (OMVs) are nanoparticles secreted by Gram-negative bacteria that can be used for diverse biotechnological applications. Interesting applications have been developed, where OMVs are the basis of drug delivery, enzyme carriers, adjuvants, and vaccines. Historically, OMV research has mainly focused on vaccines. Therefore, current OMV production processes have been based on batch processes. The production of OMVs in batch mode is characterized by relatively low yields and high costs. Transition of OMV production processes from batch to continuous processes could increase the volumetric productivity, reduce the production and capital costs, and result in a higher quality product. Here, we study the continuous production of Neisseria meningitidis OMVs to improve volumetric productivity. Continuous cultivation of N. meningitidis resulted in a steady state with similar high OMV concentrations as are reached in current batch processes. The steady state was reproducible and could be maintained for at least 600 h. The volumetric productivity of a continuous culture reached 4.0 × 10 OMVs per liter culture per day, based on a dilution rate of 1/day. The tested characteristics of the OMVs did not change during the experiments showing feasibility of a continuous production process for the production of OMVs for any application.

摘要

外膜囊泡(OMVs)是革兰氏阴性菌分泌的纳米颗粒,可用于多种生物技术应用。已经开发出了有趣的应用,其中 OMV 是药物输送、酶载体、佐剂和疫苗的基础。从历史上看,OMV 的研究主要集中在疫苗上。因此,目前的 OMV 生产工艺主要基于分批工艺。在分批模式下生产 OMV 的特点是产率相对较低,成本较高。将 OMV 生产工艺从分批向连续工艺过渡可以提高体积生产率,降低生产成本和资本成本,并生产出更高质量的产品。在这里,我们研究了脑膜炎奈瑟菌 OMV 的连续生产,以提高体积生产率。脑膜炎奈瑟菌的连续培养导致了类似于当前分批工艺中达到的高 OMV 浓度的稳定状态。该稳定状态具有重现性,至少可以维持 600 小时。基于 1/天的稀释率,连续培养的体积生产率达到了每升培养物每天 4.0×10 OMVs。在实验过程中,OMVs 的测试特性没有发生变化,表明连续生产工艺对于任何应用的 OMV 生产都是可行的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f69/6867985/ab52712f8475/253_2019_10163_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f69/6867985/3720f4ff2b5d/253_2019_10163_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f69/6867985/9bc03ec54b44/253_2019_10163_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f69/6867985/a7233857a432/253_2019_10163_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f69/6867985/ab52712f8475/253_2019_10163_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f69/6867985/3720f4ff2b5d/253_2019_10163_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f69/6867985/9bc03ec54b44/253_2019_10163_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f69/6867985/a7233857a432/253_2019_10163_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f69/6867985/ab52712f8475/253_2019_10163_Fig4_HTML.jpg

相似文献

1
Continuous production of Neisseria meningitidis outer membrane vesicles.脑膜炎奈瑟菌外膜囊泡的连续生产。
Appl Microbiol Biotechnol. 2019 Dec;103(23-24):9401-9410. doi: 10.1007/s00253-019-10163-z. Epub 2019 Nov 1.
2
High dissolved oxygen tension triggers outer membrane vesicle formation by Neisseria meningitidis.高溶解氧张力触发脑膜炎奈瑟菌外膜囊泡的形成。
Microb Cell Fact. 2018 Oct 3;17(1):157. doi: 10.1186/s12934-018-1007-7.
3
Spontaneously released Neisseria meningitidis outer membrane vesicles as vaccine platform: production and purification.脑膜炎奈瑟菌外膜囊泡作为疫苗平台的自发释放:生产和纯化。
Vaccine. 2019 Nov 8;37(47):6978-6986. doi: 10.1016/j.vaccine.2019.01.076. Epub 2019 Aug 2.
4
Outer membrane vesicles (OMV) production of Neisseria meningitidis serogroup B in batch process.脑膜炎奈瑟菌 B 群在批量生产过程中的外膜囊泡(OMV)产生。
Vaccine. 2012 Sep 14;30(42):6064-9. doi: 10.1016/j.vaccine.2012.07.052. Epub 2012 Aug 4.
5
Sulfate depletion triggers overproduction of phospholipids and the release of outer membrane vesicles by Neisseria meningitidis.硫酸盐耗竭可触发脑膜炎奈瑟菌过度产生磷脂并释放外膜囊泡。
Sci Rep. 2019 Mar 18;9(1):4716. doi: 10.1038/s41598-019-41233-x.
6
Outer membrane vesicles as platform vaccine technology.外膜囊泡作为平台疫苗技术
Biotechnol J. 2015 Sep;10(11):1689-706. doi: 10.1002/biot.201400395.
7
Phase I safety and immunogenicity study of a candidate meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles.基于乳酸奈瑟菌外膜囊泡的候选脑膜炎球菌病疫苗的I期安全性和免疫原性研究。
Clin Vaccine Immunol. 2009 Aug;16(8):1113-20. doi: 10.1128/CVI.00118-09. Epub 2009 Jun 24.
8
Human B Cell Responses to Dominant and Subdominant Antigens Induced by a Meningococcal Outer Membrane Vesicle Vaccine in a Phase I Trial.人 B 细胞对脑膜炎球菌外膜囊泡疫苗诱导的显性和次显性抗原的反应:一项 I 期临床试验。
mSphere. 2022 Feb 23;7(1):e0067421. doi: 10.1128/msphere.00674-21. Epub 2022 Jan 26.
9
Surface display of a borrelial lipoprotein on meningococcal outer membrane vesicles.疏螺旋体脂蛋白在脑膜炎球菌外膜囊泡上的表面展示。
Vaccine. 2016 Feb 17;34(8):1025-33. doi: 10.1016/j.vaccine.2016.01.019. Epub 2016 Jan 19.
10
Modulation of the biological activities of meningococcal endotoxins by association with outer membrane proteins is not inevitably linked to toxicity.脑膜炎球菌内毒素与外膜蛋白结合对其生物活性的调节并不必然与毒性相关。
Infect Immun. 1997 May;65(5):1972-9. doi: 10.1128/iai.65.5.1972-1979.1997.

引用本文的文献

1
Outer Membrane Vesicles as a Versatile Platform for Vaccine Development: Engineering Strategies, Applications and Challenges.外膜囊泡作为疫苗开发的通用平台:工程策略、应用及挑战
J Extracell Vesicles. 2025 Sep;14(9):e70150. doi: 10.1002/jev2.70150.
2
Bioengineering Outer-Membrane Vesicles for Vaccine Development: Strategies, Advances, and Perspectives.用于疫苗开发的生物工程外膜囊泡:策略、进展与展望
Vaccines (Basel). 2025 Jul 20;13(7):767. doi: 10.3390/vaccines13070767.
3
Optimization of methods for isolation and purification of outer membrane vesicles (OMVs) from Neisseria lactamica.

本文引用的文献

1
Spontaneously released Neisseria meningitidis outer membrane vesicles as vaccine platform: production and purification.脑膜炎奈瑟菌外膜囊泡作为疫苗平台的自发释放:生产和纯化。
Vaccine. 2019 Nov 8;37(47):6978-6986. doi: 10.1016/j.vaccine.2019.01.076. Epub 2019 Aug 2.
2
Sulfate depletion triggers overproduction of phospholipids and the release of outer membrane vesicles by Neisseria meningitidis.硫酸盐耗竭可触发脑膜炎奈瑟菌过度产生磷脂并释放外膜囊泡。
Sci Rep. 2019 Mar 18;9(1):4716. doi: 10.1038/s41598-019-41233-x.
3
High dissolved oxygen tension triggers outer membrane vesicle formation by Neisseria meningitidis.
从乳酸奈瑟菌中分离和纯化外膜囊泡(OMV)方法的优化。
Appl Microbiol Biotechnol. 2025 Apr 7;109(1):82. doi: 10.1007/s00253-025-13460-y.
4
Syphilis vaccine development: Aligning vaccine design with manufacturing requirements.梅毒疫苗研发:使疫苗设计与生产要求保持一致。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2399915. doi: 10.1080/21645515.2024.2399915. Epub 2024 Sep 11.
5
Bacterial extracellular vesicles: biotechnological perspective for enhanced productivity.细菌细胞外囊泡:提高生产力的生物技术视角。
World J Microbiol Biotechnol. 2024 Apr 20;40(6):174. doi: 10.1007/s11274-024-03963-7.
6
Engineered bacterial outer membrane vesicles: a versatile bacteria-based weapon against gastrointestinal tumors.工程菌外膜囊泡:一种对抗胃肠道肿瘤的多功能基于细菌的武器。
Theranostics. 2024 Jan 1;14(2):761-787. doi: 10.7150/thno.85917. eCollection 2024.
7
Bacteria-based immunotherapy for cancer: a systematic review of preclinical studies.基于细菌的癌症免疫疗法:临床前研究的系统评价。
Front Immunol. 2023 Aug 3;14:1140463. doi: 10.3389/fimmu.2023.1140463. eCollection 2023.
8
Bacterial Membrane Mimetics: From Biosensing to Disease Prevention and Treatment.细菌膜模拟物:从生物传感到疾病预防和治疗。
Biosensors (Basel). 2023 Jan 26;13(2):189. doi: 10.3390/bios13020189.
9
Bacterial extracellular vesicle applications in cancer immunotherapy.细菌细胞外囊泡在癌症免疫治疗中的应用。
Bioact Mater. 2022 Oct 31;22:551-566. doi: 10.1016/j.bioactmat.2022.10.024. eCollection 2023 Apr.
10
Bacterial outer membrane vesicle-based cancer nanovaccines.基于细菌外膜囊泡的癌症纳米疫苗。
Cancer Biol Med. 2022 Sep 23;19(9):1290-300. doi: 10.20892/j.issn.2095-3941.2022.0452.
高溶解氧张力触发脑膜炎奈瑟菌外膜囊泡的形成。
Microb Cell Fact. 2018 Oct 3;17(1):157. doi: 10.1186/s12934-018-1007-7.
4
Outer Membrane Vesicles: Current Status and Future Direction of These Novel Vaccine Adjuvants.外膜囊泡:这些新型疫苗佐剂的现状与未来方向
Front Microbiol. 2018 Apr 26;9:783. doi: 10.3389/fmicb.2018.00783. eCollection 2018.
5
Outer membrane vesicles for vaccination and targeted drug delivery.外膜囊泡用于疫苗接种和靶向药物递送。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2019 Mar;11(2):e1523. doi: 10.1002/wnan.1523. Epub 2018 Apr 26.
6
Continuous integrated manufacturing of therapeutic proteins.治疗性蛋白的连续集成制造。
Curr Opin Biotechnol. 2018 Oct;53:76-84. doi: 10.1016/j.copbio.2017.12.015. Epub 2018 Jan 4.
7
White Paper on Continuous Bioprocessing May 20-21 2014 Continuous Manufacturing Symposium.《连续生物加工白皮书》2014年5月20 - 21日连续制造研讨会
J Pharm Sci. 2015 Mar;104(3):813-820. doi: 10.1002/jps.24268. Epub 2016 Jan 8.
8
Regulatory and Quality Considerations for Continuous Manufacturing May 20-21, 2014 Continuous Manufacturing Symposium.连续制造的法规与质量考量,2014年5月20 - 21日,连续制造研讨会
J Pharm Sci. 2015 Mar;104(3):803-812. doi: 10.1002/jps.24324. Epub 2016 Jan 8.
9
High throughput nanoparticle tracking analysis for monitoring outer membrane vesicle production.用于监测外膜囊泡产生的高通量纳米颗粒跟踪分析
J Extracell Vesicles. 2017 Jun 19;6(1):1333883. doi: 10.1080/20013078.2017.1333883. eCollection 2017.
10
Integrated continuous bioprocessing: Economic, operational, and environmental feasibility for clinical and commercial antibody manufacture.集成连续生物加工:临床和商业抗体生产的经济、操作及环境可行性
Biotechnol Prog. 2017 Jul;33(4):854-866. doi: 10.1002/btpr.2492. Epub 2017 Jun 2.